|
Depreciation and amortization
|
|
$5.0m
|
$5.6m
|
$6.6m
|
$8.1m
|
$10.3m
|
$11.9m
|
$12.8m
|
|
Non-cash interest expense; amortization of debt costs
|
|
$226k
|
$211k
|
$639k
|
$921k
|
$207k
|
$339k
|
$525k
|
|
Deferred income taxes
|
|
$0
|
$0
|
$208k
|
$1.1m
|
$1.3m
|
($252k)
|
($5.9m)
|
|
Loss on impairment of long-lived assets
|
|
—
|
—
|
—
|
—
|
($212k)
|
$16k
|
$4.6m
|
|
Net loss
|
|
($2.2m)
|
$7.6m
|
$10.6m
|
($14.7m)
|
($4.5m)
|
($8.3m)
|
($11.7m)
|
|
Equity-based compensation
|
|
$341k
|
$325k
|
$7.2m
|
$29.5m
|
$18.2m
|
$3.8m
|
$2.3m
|
|
Cost related to closing location
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
$2.2m
|
|
Taxes receivable
|
|
—
|
$0
|
$0
|
($2.8m)
|
$890k
|
($1.1m)
|
$1.6m
|
|
Prepaid expense and other current assets
|
|
($1.8m)
|
$275k
|
($3.8m)
|
($5k)
|
$466k
|
($2.1m)
|
($4.4m)
|
|
Other assets
|
|
($635k)
|
($204k)
|
($1.3m)
|
($7.3m)
|
($3.8m)
|
($1.0m)
|
$6.7m
|
|
Accounts payable
|
|
$1.9m
|
($1.0m)
|
$1.6m
|
$865k
|
($206k)
|
$739k
|
$579k
|
|
Deferred revenue and patient deposits
|
|
$1.8m
|
$45k
|
($423k)
|
($452k)
|
($896k)
|
($293k)
|
$735k
|
|
Accrued and other liabilities
|
|
$392k
|
$1.1m
|
$4.8m
|
$8.2m
|
$2.2m
|
$7.6m
|
($6.8m)
|
|
Purchases of property and equipment, net
|
|
($4.4m)
|
($3.7m)
|
($7.1m)
|
($12.9m)
|
($9.9m)
|
($14.0m)
|
($2.4m)
|
|
Payments on term loan
|
|
($500k)
|
($2.9m)
|
($838k)
|
($84.3m)
|
($12.1m)
|
($2.1m)
|
($13.8m)
|
|
Payments on revolving credit facility
|
|
—
|
—
|
—
|
—
|
$0
|
$5.0m
|
($5.0m)
|
|
Proceeds from public offerings, net
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
$18.8m
|
|
Distribution to member
|
|
($283k)
|
($4.6m)
|
($66.9m)
|
($1.2m)
|
($79k)
|
$0
|
$0
|
|
Payment of taxes withheld through vested equity-based compensation
|
|
—
|
$0
|
$0
|
($2.0m)
|
($233k)
|
($903k)
|
($56k)
|
|
Beginning of period
|
|
$5.1m
|
$10.4m
|
$25.3m
|
$9.6m
|
$10.3m
|
$8.2m
|
$8.4m
|
|
Property and equipment included in accounts payable and accrued expenses
|
|
$0
|
$0
|
$255k
|
$1.1m
|
$283k
|
$1.6m
|
$1.6m
|
|
Net cash used in operating activities
|
|
$4.9m
|
$14.0m
|
$26.6m
|
$24.4m
|
$24.0m
|
$11.3m
|
$3.1m
|
|
Net cash used in investing activities
|
|
($4.4m)
|
($3.7m)
|
($7.1m)
|
($12.9m)
|
($9.9m)
|
($14.0m)
|
($2.4m)
|
|
Payments for debt modification
|
|
—
|
—
|
—
|
$0
|
$0
|
($136k)
|
($393k)
|
|
Dividends paid to shareholders
|
|
—
|
$0
|
$0
|
($23.2m)
|
($385k)
|
($252k)
|
$0
|
|
Other financing activity
|
|
—
|
$0
|
$0
|
($147k)
|
($569k)
|
($954k)
|
$0
|
|
Net cash used in financing activities
|
|
($783k)
|
($5.0m)
|
($4.5m)
|
($27.3m)
|
($13.4m)
|
$630k
|
($478k)
|
|
Net decrease in cash and cash equivalents
|
|
($284k)
|
$5.3m
|
$15.0m
|
($15.7m)
|
$646k
|
($2.0m)
|
$214k
|
|
Cash paid for interest
|
|
$2.7m
|
$2.3m
|
$4.3m
|
$5.8m
|
$6.3m
|
$6.0m
|
$5.6m
|